Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles European Journal of Cancer Year : 2023

Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status

Carmen Romero-Ferreiro
  • Function : Author
Clarisse Vindry
  • Function : Author
François Cherifi
Elouen Boughalem
  • Function : Author
Claude Linassier
Giuseppe Fornarini
  • Function : Author
Sara Rebuzzi
Maricruz Martin-Soberón
  • Function : Author
Ray Manneh
Cristina Pernaut
Ana Sanchez de Torre
  • Function : Author

Dates and versions

hal-04327294 , version 1 (06-12-2023)

Identifiers

Cite

Lucía Carril-Ajuria, Emeline Colomba, Carmen Romero-Ferreiro, Luigi Cerbone, Raffaele Ratta, et al.. Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status. European Journal of Cancer, 2023, 180, pp.21-29. ⟨10.1016/j.ejca.2022.11.013⟩. ⟨hal-04327294⟩
9 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More